Depazide-5 Tablet

Depazide-5 (Dapagliflozin 5 mg)Tablet is an effective oral anti-diabetic medication used in the management of Type 2 Diabetes Mellitus. It contains Dapagliflozin, an SGLT2 inhibitor that helps lower blood glucose levels by promoting the excretion of excess sugar through urine. This insulin-independent mechanism makes it a valuable option for patients who require improved glycemic control. In addition to controlling blood sugar, it may also support weight management and cardiovascular health, making it a well-rounded therapy in modern diabetes care. It helps control blood sugar levels by removing excess glucose from the body through urine. Depazide-5 (Dapagliflozin 5 mg) Tablet is usually prescribed along with diet control, regular exercise, and other anti-diabetic medicines to achieve effective glycemic control.Depazide-5 (Dapagliflozin 5 mg) The tablet also provides additional benefits such as weight management and cardiovascular protection, making it a preferred choice in patients with diabetes who are at risk of heart disease.

How does Depazide-5 (Dapagliflozin 5 mg) work?

SGLT2 Inhibition: By blocking SGLT2, which is responsible for ~90% of renal glucose reabsorption, it causes more glucose to be excreted through urine (glucosuria).

Insulin-Independent Action: It works regardless of insulin release or sensitivity, making it effective for type 2 diabetes management.

Cardiovascular & Renal Benefits: Beyond glucose-lowering, the osmotic diuretic effect reduces blood pressure and reduces glomerular hyperfiltration, helping to preserve kidney function and manage heart failure.

Caloric Loss: The excretion of glucose through urine leads to a reduction in body weight.

Clinical Benefits 

Effective as both monotherapy and combination therapy for type 2 diabetes, with significant reduction in HbA1c and weight, comparable to higher doses in selected patients.

Reduces the risk of cardiovascular death and hospitalization for heart failure (HHF) in patients with heart failure with reduced ejection fraction (HFrEF).

Slows the progression of chronic kidney disease (CKD), reducing the risk of end-stage kidney disease and renal death.

Causes modest weight loss, specifically reducing abdominal fat, and lowers blood pressure due to its natriuresis effect.

As an SGLT2 inhibitor, it acts independently of insulin secretion, leading to a low risk of hypoglycemia. 

Dosage & Administration

  Depazide-5 (Dapagliflozin 5 mg) Tablet should be taken as directed by the physician.

 It is usually taken once daily, with or without food.

 Swallow the tablet whole with water.

 Do not change or stop the medication without medical advice.

 Regular monitoring of blood glucose levels is recommended.

Disclaimer

Results may vary from patient to patient. This product does not cure diabetes but helps in its effective management when used as prescribed. Please consult your healthcare provider for proper diagnosis and treatment.